Skip to main content
. 2023 Dec 6;43(4):616–632. doi: 10.1002/npr2.12403

TABLE 9.

Incidence of adverse events and the list of top five most common adverse event incidence in each category.

Treatment type Adverse event n (%)
Adverse event category
Mild
Oils 826 (41.14)
Dried flower 268 (39.01)
Oils and dried flower 466 (48.14)
All treatments 1560 (42.59)
Moderate
Oils 898 (44.72)
Dried flower 306 (44.54)
Oils and dried flower 380 (39.26)
All treatments 1584 (43.24)
Severe
Oils 283 (14.09)
Dried flower 112 (16.30)
Oils and dried flower 122 (12.60)
All treatments 517 (14.11)
Life threatening/Severe
Oils 1 (0.05)
Dried flower 1 (0.15)
Oils and dried flower 0 (0.00)
All treatments 2 (0.05)
Adverse event incidence
Oils 2008 (313.26)
Dried flower 687 (292.34)
Oils and dried flower 968 (192.83)
All treatments 3663 (265.82)
Patients with adverse events
Oils 159 (11.54)
Dried flower 42 (3.05)
Oils and dried flower 96 (6.97)
All treatments 297 (21.55)
Top five most common adverse event incidence
Oils Dizziness 117 (18.26)
Dry mouth 121 (18.88)
Lethargy 125 (19.50)
Somnolence 131 (20.44)
Fatigue 151 (23.56)
Dried flower Headache 38 (16.17)
Fatigue 42 (17.87)
Concentration impairment 50 (21.28)
Somnolence 50 (21.28)
Dry mouth 55 (23.40)
Oils and dried flower Headache 54 (10.76)
Lethargy 62 (12.35)
Somnolence 69 (13.75)
Dry mouth 69 (13.75)
Fatigue 78 (15.50)
All treatments Headache 205 (14.88)
Lethargy 221 (16.04)
Dry mouth 246 (17.85)
Somnolence 250 (18.14)
Fatigue 271 (19.67)

Note: Adverse event incidence was the division of the total number of adverse events experienced by the number of patients in the corresponding treatment groups.

Abbreviation: n, number of patients.